CPC A61K 47/6901 (2017.08) [A61K 9/0019 (2013.01); A61K 9/5184 (2013.01); A61K 31/555 (2013.01); A61K 39/12 (2013.01); A61P 35/00 (2018.01); A61K 2039/585 (2013.01); C12N 2750/12022 (2013.01); C12N 2750/12023 (2013.01); C12N 2770/00034 (2013.01); C12N 2770/00042 (2013.01); C12N 2770/32022 (2013.01); C12N 2770/32023 (2013.01)] | 12 Claims |
1. An anticancer virus particle, comprising a tobacco mosaic virus particle and a cationic platinum-based anticancer agent and any carrier for the agent are non-covalently encapsulated within an interior channel of the tobacco mosaic virus particle.
|